EAM
LLY icon

Exane Asset Management’s Eli Lilly LLY Stock Holding History

Exane Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$89.7K – 42
2025
Q3 		$89.7K Sell
100
-4,294
-98% -$3.2M 0.03% 25
2025
Q2 		$4.02M Buy
+4,394
New +$3.41M 1.57% 14
2020
Q4 		– Sell
-30,000
Closed -$4.44M – 24
2020
Q3 		$4.44M Buy
+30,000
New +$4.64M 2.91% 8
2016
Q4 		– Sell
-20,402
Closed -$1.64M – 38
2016
Q3 		$1.64M Buy
+20,402
New +$1.63M 0.51% 33

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Exane Asset Management's LLY Position: Q4 2025 in Review

Exane Asset Management sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 100 shares — an estimated $89.7K sold.

Exane Asset Management first reported a position in LLY in Q3 2016 and held it in 4 quarters. The position peaked at $4.44M in Q3 2020. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Exane Asset Management reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • Exane Asset Management sold 100 Eli Lilly shares in Q4 2025, an estimated $89.7K.
  • Exane Asset Management first reported a position in Eli Lilly in Q3 2016 and held it in 4 quarters.
  • Exane Asset Management's Eli Lilly position peaked at $4.44M in Q3 2020.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Exane Asset Management's 13F filing for Q4 2025, filed 27 Jan 2026.